Table I.
Demographic differences among subjects admitted from long-term care facility (LTCF) and home
| Total (N = 196) |
Admitted from home [n = 168 (76%)] |
Admitted from LTCF [n = 28 (13%)] |
OR | 95% CI |
P- value |
|
|---|---|---|---|---|---|---|
| Age ≥60 years | 105 (54) | 80 (48) | 25 (89) | 9.17 | 2.67–31.53 | <0.001 |
| Comorbidity score | ||||||
| ≥3 | 148 (76) | 125 (74) | 23 (82) | 1.58 | 0.57–4.42 | 0.480 |
| ≥4 | 122 (62) | 105 (63) | 17 (61) | 0.93 | 0.41–2.11 | 0.837 |
| ≥5 | 97 (50) | 83 (49) | 14 (50) | 1.02 | 0.46–2.28 | 1.000 |
| BMI ≤18.5 kg/m2 | 13 (7) | 9 (6) | 4 (17) | 3.65 | 1.02–13.0 | 0.058 |
| SIRS score ≥2 | 115 (59) | 100 (60) | 15 (54) | 0.79 | 0.35–1.75 | 0.679 |
| Nosocomial CDI | 83 (42) | 75 (45) | 8 (29) | 2.02 | 0.84–4.83 | 0.148 |
| Current antibiotic use | 154 (79) | 128 (76) | 26 (93) | 4.06 | 0.92–17.87 | 0.049 |
| Multiple antibiotics | 125 (64) | 102 (62) | 21 (75) | 1.85 | 0.74–4.59 | 0.208 |
| Acid suppression | 155 (79) | 133 (79) | 22 (79) | 0.97 | 0.36–2.56 | 1.000 |
| Ribotype 027 | 77 (39) | 57 (34) | 20 (71) | 4.87 | 2.02–11.74 | <0.001 |
| Fluoroquinolone resistance | 94 (48) | 73 (44) | 21 (75) | 3.90 | 1.57–9.68 | 0.002 |
OR, odds ratio; CI, confidence interval; BMI, body mass index; SIRS, systemic inflammatory response syndrome; CDI, Clostridium difficile infection.